Evaluation of RNA amplification methods to improve DC immunotherapy antigen presentation and immune response

Molecular Therapy Nucleic Acids

Volumn 2, Issue , 2013, Pages e91-

  Slagter Jäger, Jacoba G ^a   Raney, Alexa ^b   Lewis, Whitney E ^a   DeBenedette, Mark A ^a   Nicolette, Charles A ^a   Tcherepanova, Irina Y ^a  

^a Argos Therapeutics Inc   (United States)

^b NOVARTIS   (United States)

Author keywords

Dendritic cell; PCR; RNA; RNA amplification; RNA cap

Indexed keywords

RNA;

ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; CELL EXPANSION; COCULTURE; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; ELECTROPORATION; GEL ELECTROPHORESIS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; MICROARRAY ANALYSIS; NORTHERN BLOTTING; NUCLEIC ACID AMPLIFICATION; POLYMERASE CHAIN REACTION; POSTTRANSCRIPTIONAL GENE SILENCING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA AMPLIFICATION; RNA CAPPING; RNA TRANSLATION;

EID: 84878882515     PISSN: None     EISSN: 21622531     Source Type: Journal    
DOI: 10.1038/mtna.2013.18     Document Type: Article

References (46)

1. Castanotto, D and Rossi, JJ (2009). The promises and pitfalls of RNA-interference-based therapeutics. Nature 457: 426-433.
2. Burnett, JC and Rossi, JJ (2012). RNA-based therapeutics: current progress and future prospects. Chem Biol 19: 60-71.
3. Creusot, RJ, Chang, P, Healey, DG, Tcherepanova, IY, Nicolette, CA and Fathman, CG (2010). A short pulse of IL-4 delivered by DCs electroporated with modified mRNA can both prevent and treat autoimmune diabetes in NOD mice. Mol Ther 18: 2112-2120.
4. Tcherepanova, IY, Adams, MD, Feng, X, Hinohara, A, Horvatinovich, J, Calderhead, D et al. (2008). Ectopic expression of a truncated CD40L protein from synthetic post-transcriptionally capped RNA in dendritic cells induces high levels of IL-12 secretion. BMC Mol Biol 9: 90.
5. Karikó, K, Muramatsu, H, Keller, JM and Weissman, D (2012). Increased erythropoiesis in mice injected with submicrogram quantities of pseudouridine-containing mRNA encoding erythropoietin. Mol Ther 20: 948-953.
6. Kormann, MS, Hasenpusch, G, Aneja, MK, Nica, G, Flemmer, AW, Herber-Jonat, S et al. (2011). Expression of therapeutic proteins after delivery of chemically modified mRNA in mice. Nat Biotechnol 29: 154-157.
7. Rittig, SM, Haentschel, M, Weimer, KJ, Heine, A, Muller, MR, Brugger, W et al. (2011). Intradermal vaccinations with RNA coding for TAA generate CD8+ and CD4+ immune responses and induce clinical benefit in vaccinated patients. Mol Ther 19: 990-999.
8. Weide, B, Carralot, JP, Reese, A, Scheel, B, Eigentler, TK, Hoerr, I et al. (2008). Results of the first phase I/II clinical vaccination trial with direct injection of mRNA. J Immunother 31: 180-188.
9. Bringmann, A, Held, SA, Heine, A and Brossart, P (2010). RNA vaccines in cancer treatment. J Biomed Biotechnol 2010: 623687.
10. Van Gulck, E, Vlieghe, E, Vekemans, M, Van Tendeloo, VF, Van De Velde, A, Smits, E et al. (2012). mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients. AIDS 26: F1-12.
11. Routy, JP, Boulassel, MR, Yassine-Diab, B, Nicolette, C, Healey, D, Jain, R et al. (2010). Immunologic activity and safety of autologous HIV RNA-electroporated dendritic cells in HIV-1 infected patients receiving antiretroviral therapy. Clin Immunol 134: 140-147.
12. Su, Z, Dannull, J, Yang, BK, Dahm, P, Coleman, D, Yancey, D et al. (2005). Telomerase mRNA-transfected dendritic cells stimulate antigen-specific CD8+ and CD4+ T cell responses in patients with metastatic prostate cancer. J Immunol 174: 3798-3807. (Pubitemid 40354093)
13. Heiser, A, Coleman, D, Dannull, J, Yancey, D, Maurice, MA, Lallas, CD et al. (2002). Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors. J Clin Invest 109: 409-417. (Pubitemid 34141815)
14. Benencia, F, Courrèges, MC and Coukos, G (2008). Whole tumor antigen vaccination using dendritic cells: comparison of RNA electroporation and pulsing with UV-irradiated tumor cells. J Transl Med 6: 21.
15. Pan, K, Zhao, JJ, Wang, H, Li, JJ, Liang, XT, Sun, JC et al. (2010). Comparative analysis of cytotoxic T lymphocyte response induced by dendritic cells loaded with hepatocellular carcinoma -derived RNA or cell lysate. Int J Biol Sci 6: 639-648.
16. Heiser, A, Maurice, MA, Yancey, DR, Wu, NZ, Dahm, P, Pruitt, SK et al. (2001). Induction of polyclonal prostate cancer-specific CTL using dendritic cells transfected with amplified tumor RNA. J Immunol 166: 2953-2960. (Pubitemid 33117290)
17. Boczkowski, D, Nair, SK, Nam, JH, Lyerly, HK and Gilboa, E (2000). Induction of tumor immunity and cytotoxic T lymphocyte responses using dendritic cells transfected with messenger RNA amplified from tumor cells. Cancer Res 60: 1028-1034. (Pubitemid 30129541)
18. Harris, J, Monesmith, T, Ubben, A, Norris, M, Freedman, JH and Tcherepanova, I (2005). An improved RNA amplification procedure results in increased yield of autologous RNA transfected dendritic cell-based vaccine. Biochim Biophys Acta 1724: 127-136. (Pubitemid 40799118)
19. Karikó, K, Muramatsu, H, Ludwig, J and Weissman, D (2011). Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA. Nucleic Acids Res 39: e142.
20. Minami, K, Yamaguchi, Y, Ohshita, A, Kawabuchi, Y, Ohta, K, Hihara, J et al. (2005). Generation of antigen-presenting cells using cultured dendritic cells and amplified autologous tumor mRNA. Oncology 69: 399-407. (Pubitemid 41797916)
21. Markovic, SN, Dietz, AB, Greiner, CW, Maas, ML, Butler, GW, Padley, DJ et al. (2006). Preparing clinical-grade myeloid dendritic cells by electroporation-mediated transfection of in vitro amplified tumor-derived mRNA and safety testing in stage IV malignant melanoma. J Transl Med 4: 35.
22. Kalady, MF, Onaitis, MW, Padilla, KM, Emani, S, Tyler, DS and Pruitt, SK (2002). Enhanced dendritic cell antigen presentation in RNA-based immunotherapy. J Surg Res 105: 17-24. (Pubitemid 34713206)
23. Van Tendeloo, VF, Ponsaerts, P, Lardon, F, Nijs, G, Lenjou, M, Van Broeckhoven, C et al. (2001). Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells. Blood 98: 49-56.
24. Van Tendeloo, VF, Ponsaerts, P and Berneman, ZN (2007). mRNA-based gene transfer as a tool for gene and cell therapy. Curr Opin Mol Ther 9: 423-431. (Pubitemid 47574618)
25. Mitchell, DA and Nair, SK (2000). RNA-transfected dendritic cells in cancer immunotherapy. J Clin Invest 106: 1065-1069.
26. Grünebach, F, Müller, MR, Nencioni, A and Brossart, P (2003). Delivery of tumor-derived RNA for the induction of cytotoxic T-lymphocytes. Gene Ther 10: 367-374. (Pubitemid 36372444)
27. Takahashi, M, Narita, M, Ayres, F, Satoh, N, Abe, T, Yanao, T et al. (2003). Cytoplasmic expression of EGFP in dendritic cells transfected with in vitro transcribed mRNA or cellular total RNA extracted from EGFP expressing leukemia cells. Med Oncol 20: 335-348. (Pubitemid 38021484)
28. Corish, P and Tyler-Smith, C (1999). Attenuation of green fluorescent protein half-life in mammalian cells. Protein Eng 12: 1035-1040. (Pubitemid 30011478)
29. Tang, GQ, Bandwar, RP and Patel, SS (2005). Extended upstream A-T sequence increases T7 promoter strength. J Biol Chem 280: 40707-40713. (Pubitemid 41782232)
30. Calderhead, DM, DeBenedette, MA, Ketteringham, H, Gamble, AH, Horvatinovich, JM, Tcherepanova, IY et al. (2008). Cytokine maturation followed by CD40L mRNA electroporation results in a clinically relevant dendritic cell product capable of inducing a potent proinflammatory CTL response. J Immunother 31: 731-741.
31. DeBenedette, MA, Calderhead, DM, Ketteringham, H, Gamble, AH, Horvatinovich, JM, Tcherepanova, IY et al. (2008). Priming of a novel subset of CD28+ rapidly expanding high-avidity effector memory CTL by post maturation electroporation-CD40L dendritic cells is IL-12 dependent. J Immunol 181: 5296-5305.
32. DeBenedette, MA, Calderhead, DM, Tcherepanova, IY, Nicolette, CA and Healey, DG (2011). Potency of mature CD40L RNA electroporated dendritic cells correlates with IL-12 secretion by tracking multifunctional CD8(+)/CD28(+) cytotoxic T-cell responses in vitro. J Immunother 34: 45-57.
33. Godler, DE, Loesch, DZ, Huggins, R, Gordon, L, Slater, HR, Gehling, F et al. (2009). Improved methodology for assessment of mRNA levels in blood of patients with FMR1 related disorders. BMC Clin Pathol 9: 5.
34. Fleige, S and Pfaffl, MW (2006). RNA integrity and the effect on the real-time qRT-PCR performance. Mol Aspects Med 27: 126-139.
35. Imbeaud, S, Graudens, E, Boulanger, V, Barlet, X, Zaborski, P, Eveno, E et al. (2005). Towards standardization of RNA quality assessment using user-independent classifiers of microcapillary electrophoresis traces. Nucleic Acids Res 33: e56.
36. Schroeder, A, Mueller, O, Stocker, S, Salowsky, R, Leiber, M, Gassmann, M et al. (2006). The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol 7: 3.
37. Gilboa, E and Vieweg, J (2004). Cancer immunotherapy with mRNA-transfected dendritic cells. Immunol Rev 199: 251-263. (Pubitemid 38744521)
38. Gingras, AC, Raught, B and Sonenberg, N (1999). eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Annu Rev Biochem 68: 913-963. (Pubitemid 29449212)
39. Pasquinelli, AE, Dahlberg, JE and Lund, E (1995). Reverse 5' caps in RNAs made in vitro by phage RNA polymerases. RNA 1: 957-967.
40. Marcotrigiano, J, Gingras, AC, Sonenberg, N and Burley, SK (1997). Cocrystal structure of the messenger RNA 5' cap-binding protein (eIF4E) bound to 7-methyl-GDP. Cell 89: 951-961. (Pubitemid 27513521)
41. Stepinski, J, Waddell, C, Stolarski, R, Darzynkiewicz, E and Rhoads, RE (2001). Synthesis and properties of mRNAs containing the novel "anti-reverse" cap analogs 7-methyl(3'-Omethyl) GpppG and 7-methyl (3'-deoxy)GpppG. RNA 7: 1486-1495. (Pubitemid 32973234)
42. Grudzien-Nogalska, E, Kowalska, J, Su, W, Kuhn, AN, Slepenkov, SV, Darzynkiewicz, E et al. (2013). Synthetic mRNAs with superior translation and stability properties. In: Rabinovich, PM (ed.). Synthetic Messenger RNA and Cell Metabolism Modulation: Methods and Protocols, Methods in Molecular Biology, vol. 969. Springer Science+Business Media: New York. pp. 55-73.
43. Venkatesan, S, Gershowitz, A and Moss, B (1980). Modification of the 5' end of mRNA. Association of RNA triphosphatase with the RNA guanylyltransferase- RNA (guanine-7-) methyltransferase complex from vaccinia virus. J Biol Chem 255: 903-908.
44. Kuge, H, Brownlee, GG, Gershon, PD and Richter, JD (1998). Cap ribose methylation of cmos mRNA stimulates translation and oocyte maturation in Xenopus laevis. Nucleic Acids Res 26: 3208-3214. (Pubitemid 28288920)
45. Seder, RA, Darrah, PA and Roederer, M (2008). T-cell quality in memory and protection: implications for vaccine design. Nat Rev Immunol 8: 247-258. (Pubitemid 351432801)
46. Gumz, ML, Zou, H, Kreinest, PA, Childs, AC, Belmonte, LS, LeGrand, SN et al. (2007). Secreted frizzled-related protein 1 loss contributes to tumor phenotype of clear cell renal cell carcinoma. Clin Cancer Res 13: 4740-4749. (Pubitemid 47294780)